teva uk limited
teva uk limited Company Information
Company Number
00302461
Website
www.tevauk.comRegistered Address
ridings point whistler drive, castleford, england, WF10 5HX
Industry
Manufacture of pharmaceutical preparations
Telephone
01977628500
Next Accounts Due
September 2024
Group Structure
View All
Shareholders
teva uk holdings ltd 100%
teva uk limited Estimated Valuation
The estimated valuation range for teva uk limited, derived from financial data as of December 2022 and the most recent industry multiples, is between £406.9m to £1.1b
teva uk limited Estimated Valuation
The estimated valuation range for teva uk limited, derived from financial data as of December 2022 and the most recent industry multiples, is between £406.9m to £1.1b
teva uk limited Estimated Valuation
The estimated valuation range for teva uk limited, derived from financial data as of December 2022 and the most recent industry multiples, is between £406.9m to £1.1b
Get a detailed valuation report, edit figures and unlock valuation multiples.
Teva Uk Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Teva Uk Limited Overview
Teva Uk Limited is a live company located in england, WF10 5HX with a Companies House number of 00302461. It operates in the manufacture of pharmaceutical preparations sector, SIC Code 21200. Founded in July 1935, it's largest shareholder is teva uk holdings ltd with a 100% stake. Teva Uk Limited is a mature, mega sized company, Pomanda has estimated its turnover at £491.7m with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
Teva Uk Limited Health Check
Pomanda's financial health check has awarded Teva Uk Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 6 areas for improvement. Company Health Check FAQs
4 Strong
2 Regular
6 Weak
Size
annual sales of £491.7m, make it larger than the average company (£24.1m)
£491.7m - Teva Uk Limited
£24.1m - Industry AVG
Growth
3 year (CAGR) sales growth of 0%, show it is growing at a slower rate (1.9%)
- Teva Uk Limited
1.9% - Industry AVG
Production
with a gross margin of 24.9%, this company has a higher cost of product (34.6%)
24.9% - Teva Uk Limited
34.6% - Industry AVG
Profitability
an operating margin of 7.9% make it more profitable than the average company (6%)
7.9% - Teva Uk Limited
6% - Industry AVG
Employees
with 450 employees, this is above the industry average (106)
450 - Teva Uk Limited
106 - Industry AVG
Pay Structure
on an average salary of £108.4k, the company has a higher pay structure (£54.3k)
£108.4k - Teva Uk Limited
£54.3k - Industry AVG
Efficiency
resulting in sales per employee of £1.1m, this is more efficient (£273.7k)
£1.1m - Teva Uk Limited
£273.7k - Industry AVG
Debtor Days
it gets paid by customers after 84 days, this is later than average (61 days)
84 days - Teva Uk Limited
61 days - Industry AVG
Creditor Days
its suppliers are paid after 23 days, this is quicker than average (37 days)
23 days - Teva Uk Limited
37 days - Industry AVG
Stock Days
it holds stock equivalent to 104 days, this is in line with average (101 days)
104 days - Teva Uk Limited
101 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (10 weeks)
0 weeks - Teva Uk Limited
10 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 43.9%, this is a similar level of debt than the average (43.9%)
43.9% - Teva Uk Limited
43.9% - Industry AVG
teva uk limited Credit Report and Business Information
Teva Uk Limited Competitor Analysis
Perform a competitor analysis for teva uk limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
teva uk limited Ownership
TEVA UK LIMITED group structure
Teva Uk Limited has no subsidiary companies.
Ultimate parent company
TEVA PHARMACEUTICAL INDUSTRIES LTD
#0018335
2 parents
TEVA UK LIMITED
00302461
teva uk limited directors
Teva Uk Limited currently has 3 directors. The longest serving directors include Mr David Vrhovec (May 2016) and Ms Kim Innes (Sep 2016).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr David Vrhovec | England | 56 years | May 2016 | - | Director |
| Ms Kim Innes | England | 55 years | Sep 2016 | - | Director |
| Mr Stephen Charlesworth | United Kingdom | 57 years | Apr 2020 | - | Director |
TEVA UK LIMITED financials
Teva Uk Limited's latest turnover from December 2022 is £491.7 million and the company has net assets of £332.9 million. According to their latest financial statements, Teva Uk Limited has 450 employees and maintains cash reserves of £2.1 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 491,748,000 | 440,826,000 | 476,265,000 | 486,164,000 | 551,389,000 | 522,216,000 | 413,804,000 | 362,910,000 | 385,823,000 | 383,491,000 | 354,880,000 | 381,405,000 | 285,068,000 | 242,910,000 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost Of Sales | 369,199,000 | 323,134,000 | 350,169,000 | 344,534,000 | 416,538,000 | 409,510,000 | 291,333,000 | 265,938,000 | 277,745,000 | 295,829,000 | 294,480,000 | 310,682,000 | 220,616,000 | 216,520,000 |
| Gross Profit | 122,549,000 | 117,692,000 | 126,096,000 | 141,630,000 | 134,851,000 | 112,706,000 | 122,471,000 | 96,972,000 | 108,078,000 | 87,662,000 | 60,400,000 | 70,723,000 | 64,452,000 | 26,390,000 |
| Admin Expenses | 83,928,000 | 80,042,000 | 87,834,000 | 98,190,000 | 103,427,000 | 90,128,000 | 106,804,000 | 77,375,000 | 71,696,000 | 64,745,000 | 61,448,000 | 68,528,000 | 54,906,000 | 33,542,000 |
| Operating Profit | 38,621,000 | 37,650,000 | 38,262,000 | 43,440,000 | 31,424,000 | 22,578,000 | 15,667,000 | 19,597,000 | 36,382,000 | 22,917,000 | -1,048,000 | 2,195,000 | 9,546,000 | -7,152,000 |
| Interest Payable | 2,438,000 | 1,194,000 | 1,350,000 | 1,474,000 | 2,690,000 | 1,429,000 | 2,558,000 | 3,370,000 | 2,413,000 | 2,513,000 | 2,839,000 | 4,689,000 | 3,464,000 | 3,093,000 |
| Interest Receivable | 10,993,000 | 7,230,000 | 3,223,000 | 1,580,000 | 1,806,000 | 1,456,000 | 1,843,000 | 2,449,000 | 1,644,000 | 980,000 | 869,000 | 3,841,000 | 2,668,000 | 1,224,000 |
| Pre-Tax Profit | 47,176,000 | 43,686,000 | 40,135,000 | 43,546,000 | 30,540,000 | 17,810,000 | 14,952,000 | 18,676,000 | 32,947,000 | 7,998,000 | -3,337,000 | 1,556,000 | 8,750,000 | -9,442,000 |
| Tax | -9,370,000 | -9,278,000 | -8,076,000 | -10,343,000 | -6,285,000 | -5,242,000 | -4,693,000 | -2,753,000 | -9,132,000 | -6,018,000 | -2,372,000 | 8,914,000 | 0 | 0 |
| Profit After Tax | 37,806,000 | 34,408,000 | 32,059,000 | 33,203,000 | 24,255,000 | 12,568,000 | 10,259,000 | 15,923,000 | 23,815,000 | 1,980,000 | -5,709,000 | 10,470,000 | 8,750,000 | -9,442,000 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | 37,806,000 | 34,408,000 | 32,059,000 | 33,203,000 | 24,255,000 | 12,568,000 | 10,259,000 | 15,923,000 | 23,815,000 | 1,980,000 | -5,709,000 | 10,470,000 | 8,750,000 | -9,442,000 |
| Employee Costs | 48,766,000 | 49,789,000 | 53,942,000 | 54,859,000 | 61,983,000 | 61,808,000 | 64,707,000 | 60,388,000 | 54,231,000 | 51,221,000 | 47,650,000 | 40,331,000 | 37,725,000 | 26,667,000 |
| Number Of Employees | 450 | 488 | 567 | 600 | 674 | 792 | 772 | 740 | 715 | 707 | 701 | 665 | 678 | 578 |
| EBITDA* | 41,348,000 | 40,614,000 | 46,722,000 | 48,545,000 | 36,372,000 | 26,331,000 | 19,630,000 | 23,426,000 | 40,436,000 | 24,542,000 | 3,762,000 | 7,071,000 | 16,591,000 | -2,163,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 5,604,000 | 6,195,000 | 11,906,000 | 21,822,000 | 24,301,000 | 26,710,000 | 27,211,000 | 27,925,000 | 27,626,000 | 34,819,000 | 35,192,000 | 36,845,000 | 37,398,000 | 40,118,000 |
| Intangible Assets | 3,370,000 | 4,681,000 | 6,017,000 | 7,958,000 | 10,192,000 | 8,368,000 | 9,414,000 | 10,663,000 | 11,135,000 | 11,943,000 | 13,045,000 | 14,448,000 | 15,948,000 | 17,430,000 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 250,000 | 250,000 | 250,000 | 250,000 | 250,000 | 250,000 |
| Debtors (Due After 1 year) | 130,063,000 | 130,163,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 139,037,000 | 141,039,000 | 17,923,000 | 29,780,000 | 34,493,000 | 35,078,000 | 36,625,000 | 38,588,000 | 39,011,000 | 47,012,000 | 48,487,000 | 51,543,000 | 53,596,000 | 57,798,000 |
| Stock & work in progress | 105,292,000 | 110,885,000 | 124,331,000 | 121,761,000 | 132,139,000 | 159,887,000 | 139,300,000 | 99,024,000 | 117,876,000 | 100,317,000 | 115,357,000 | 100,722,000 | 94,517,000 | 68,143,000 |
| Trade Debtors | 114,101,000 | 66,548,000 | 74,258,000 | 68,840,000 | 83,860,000 | 107,316,000 | 98,793,000 | 75,624,000 | 63,744,000 | 63,920,000 | 59,959,000 | 118,899,000 | 65,613,000 | 54,556,000 |
| Group Debtors | 220,606,000 | 169,383,000 | 222,622,000 | 226,732,000 | 193,945,000 | 246,418,000 | 366,558,000 | 327,915,000 | 267,595,000 | 229,241,000 | 204,178,000 | 144,437,000 | 80,444,000 | 69,546,000 |
| Misc Debtors | 12,669,000 | 15,753,000 | 24,669,000 | 6,951,000 | 5,724,000 | 8,253,000 | 7,741,000 | 6,215,000 | 7,269,000 | 7,899,000 | 15,426,000 | 17,487,000 | 8,384,000 | 6,517,000 |
| Cash | 2,075,000 | 2,311,000 | 2,338,000 | 1,058,000 | 23,355,000 | 4,650,000 | 6,354,000 | 17,096,000 | 18,363,000 | 19,088,000 | 11,753,000 | 9,717,000 | 2,845,000 | 6,509,000 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 454,743,000 | 364,880,000 | 448,218,000 | 425,342,000 | 439,023,000 | 526,524,000 | 618,746,000 | 525,874,000 | 474,847,000 | 420,465,000 | 406,673,000 | 391,262,000 | 251,803,000 | 205,271,000 |
| total assets | 593,780,000 | 505,919,000 | 466,141,000 | 455,122,000 | 473,516,000 | 561,602,000 | 655,371,000 | 564,462,000 | 513,858,000 | 467,477,000 | 455,160,000 | 442,805,000 | 305,399,000 | 263,069,000 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14,396,000 | 0 | 0 | 0 | 0 | 45,099,000 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 23,832,000 | 21,254,000 | 28,476,000 | 21,994,000 | 18,588,000 | 36,001,000 | 27,709,000 | 30,050,000 | 42,625,000 | 29,485,000 | 33,784,000 | 27,006,000 | 24,618,000 | 23,208,000 |
| Group/Directors Accounts | 108,713,000 | 80,995,000 | 59,162,000 | 152,437,000 | 99,898,000 | 252,452,000 | 402,329,000 | 365,584,000 | 306,113,000 | 290,098,000 | 370,591,000 | 361,820,000 | 245,833,000 | 191,820,000 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 82,000 | 270,000 | 281,000 |
| other current liabilities | 123,129,000 | 106,075,000 | 113,626,000 | 40,731,000 | 152,369,000 | 179,657,000 | 148,436,000 | 115,258,000 | 118,055,000 | 101,462,000 | 18,263,000 | 10,428,000 | 13,311,000 | 11,047,000 |
| total current liabilities | 255,674,000 | 208,324,000 | 201,264,000 | 215,162,000 | 270,855,000 | 468,110,000 | 578,474,000 | 510,892,000 | 481,189,000 | 421,045,000 | 422,638,000 | 399,336,000 | 284,032,000 | 271,455,000 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 272,000 | 533,000 |
| Accruals and Deferred Income | 0 | 0 | 0 | 10,036,000 | 12,842,000 | 15,148,000 | 12,594,000 | 2,789,000 | 0 | 27,398,000 | 27,423,000 | 30,227,000 | 18,710,000 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 791,000 | 953,000 | 3,985,000 | 4,803,000 | 820,000 | 1,060,000 | 1,562,000 | 1,975,000 | 2,047,000 | 14,740,000 | 3,040,000 | 1,471,000 | 2,048,000 | 0 |
| total long term liabilities | 5,182,000 | 6,961,000 | 15,774,000 | 21,687,000 | 21,074,000 | 26,656,000 | 25,981,000 | 9,226,000 | 10,126,000 | 45,754,000 | 38,558,000 | 42,751,000 | 29,180,000 | 14,344,000 |
| total liabilities | 260,856,000 | 215,285,000 | 217,038,000 | 236,849,000 | 291,929,000 | 494,766,000 | 604,455,000 | 520,118,000 | 491,315,000 | 466,799,000 | 461,196,000 | 442,087,000 | 313,212,000 | 285,799,000 |
| net assets | 332,924,000 | 290,634,000 | 249,103,000 | 218,273,000 | 181,587,000 | 66,836,000 | 50,916,000 | 44,344,000 | 22,543,000 | 678,000 | -6,036,000 | 718,000 | -7,813,000 | -22,730,000 |
| total shareholders funds | 332,924,000 | 290,634,000 | 249,103,000 | 218,273,000 | 181,587,000 | 66,836,000 | 50,916,000 | 44,344,000 | 22,543,000 | 678,000 | -6,036,000 | 718,000 | -7,813,000 | -22,730,000 |
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | 38,621,000 | 37,650,000 | 38,262,000 | 43,440,000 | 31,424,000 | 22,578,000 | 15,667,000 | 19,597,000 | 36,382,000 | 22,917,000 | -1,048,000 | 2,195,000 | 9,546,000 | -7,152,000 |
| Depreciation | 994,000 | 1,238,000 | 6,401,000 | 2,871,000 | 2,387,000 | 2,241,000 | 2,383,000 | 2,280,000 | 2,663,000 | 323,000 | 3,376,000 | 3,376,000 | 5,563,000 | 4,823,000 |
| Amortisation | 1,733,000 | 1,726,000 | 2,059,000 | 2,234,000 | 2,561,000 | 1,512,000 | 1,580,000 | 1,549,000 | 1,391,000 | 1,302,000 | 1,434,000 | 1,500,000 | 1,482,000 | 166,000 |
| Tax | -9,370,000 | -9,278,000 | -8,076,000 | -10,343,000 | -6,285,000 | -5,242,000 | -4,693,000 | -2,753,000 | -9,132,000 | -6,018,000 | -2,372,000 | 8,914,000 | 0 | 0 |
| Stock | -5,593,000 | -13,446,000 | 2,570,000 | -10,378,000 | -27,748,000 | 20,587,000 | 40,276,000 | -18,852,000 | 17,559,000 | -15,040,000 | 14,635,000 | 6,205,000 | 26,374,000 | 68,143,000 |
| Debtors | 95,592,000 | 60,298,000 | 19,026,000 | 18,994,000 | -78,458,000 | -111,105,000 | 63,338,000 | 71,146,000 | 37,548,000 | 21,497,000 | -1,260,000 | 126,382,000 | 23,822,000 | 130,619,000 |
| Creditors | 2,578,000 | -7,222,000 | 6,482,000 | 3,406,000 | -17,413,000 | 8,292,000 | -2,341,000 | -12,575,000 | 13,140,000 | -4,299,000 | 6,778,000 | 2,388,000 | 1,410,000 | 23,208,000 |
| Accruals and Deferred Income | 17,054,000 | -7,551,000 | 62,859,000 | -114,444,000 | -29,594,000 | 33,775,000 | 42,983,000 | -8,000 | -10,805,000 | 83,174,000 | 5,031,000 | 8,634,000 | 20,974,000 | 11,047,000 |
| Deferred Taxes & Provisions | -162,000 | -3,032,000 | -818,000 | 3,983,000 | -240,000 | -502,000 | -413,000 | -72,000 | -12,693,000 | 11,700,000 | 1,569,000 | -577,000 | 2,048,000 | 0 |
| Cash flow from operations | -38,551,000 | -33,321,000 | 85,573,000 | -77,469,000 | 89,046,000 | 153,172,000 | -48,448,000 | -44,276,000 | -34,161,000 | 102,642,000 | 1,393,000 | -106,157,000 | -9,173,000 | -166,670,000 |
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -250,000 | 0 | 0 | 0 | 0 | 0 | 250,000 |
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 27,718,000 | 21,833,000 | -93,275,000 | 52,539,000 | -152,554,000 | -149,877,000 | 36,745,000 | 59,471,000 | 16,015,000 | -80,493,000 | 8,771,000 | 115,987,000 | 54,013,000 | 191,820,000 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -82,000 | -460,000 | -272,000 | 814,000 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | 8,555,000 | 6,036,000 | 1,873,000 | 106,000 | -884,000 | 27,000 | -715,000 | -921,000 | -769,000 | -1,533,000 | -1,970,000 | -848,000 | -796,000 | -1,869,000 |
| cash flow from financing | 40,757,000 | 34,992,000 | -92,631,000 | 56,128,000 | -62,942,000 | -146,498,000 | 32,343,000 | 64,428,000 | 13,296,000 | -77,292,000 | 5,674,000 | 112,740,000 | 59,112,000 | 177,477,000 |
| cash and cash equivalents | ||||||||||||||
| cash | -236,000 | -27,000 | 1,280,000 | -22,297,000 | 18,705,000 | -1,704,000 | -10,742,000 | -1,267,000 | -725,000 | 7,335,000 | 2,036,000 | 6,872,000 | -3,664,000 | 6,509,000 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -14,396,000 | 14,396,000 | 0 | 0 | 0 | -45,099,000 | 45,099,000 |
| change in cash | -236,000 | -27,000 | 1,280,000 | -22,297,000 | 18,705,000 | -1,704,000 | -10,742,000 | 13,129,000 | -15,121,000 | 7,335,000 | 2,036,000 | 6,872,000 | 41,435,000 | -38,590,000 |
P&L
December 2022turnover
491.7m
+12%
operating profit
38.6m
+3%
gross margin
25%
-6.66%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
332.9m
+0.15%
total assets
593.8m
+0.17%
cash
2.1m
-0.1%
net assets
Total assets minus all liabilities
teva uk limited company details
company number
00302461
Type
Private limited with Share Capital
industry
21200 - Manufacture of pharmaceutical preparations
incorporation date
July 1935
age
89
accounts
Full Accounts
ultimate parent company
previous names
approved prescription services limited (November 2004)
incorporated
UK
address
ridings point whistler drive, castleford, england, WF10 5HX
last accounts submitted
December 2022
teva uk limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 8 charges/mortgages relating to teva uk limited. Currently there are 0 open charges and 8 have been satisfied in the past.
teva uk limited Companies House Filings - See Documents
| date | description | view/download |
|---|
